|1.||Lequesne, M: 1 article (04/2001)|
|2.||Gollerova, V: 1 article (09/2000)|
|3.||Pavelká, K: 1 article (09/2000)|
|4.||Sedlácková, M: 1 article (09/2000)|
|5.||Zupanets, I A: 1 article (09/2000)|
|6.||Altman, R D: 1 article (09/2000)|
|7.||Misiureva, S V: 1 article (09/2000)|
|8.||Gatterová, J: 1 article (09/2000)|
|9.||Urbanová, Z: 1 article (09/2000)|
|10.||Berg, P A: 1 article (02/2000)|
04/01/2001 - "A 5-year randomized controlled double-bling study of glycosaminoglycan polysulfuric acid complex (Rumalon) as a structure-modifying therapy in osteoarthritis of the hip and knee. "
01/01/1989 - "A single-blind, placebo-controlled study of glycosaminoglycan-peptide complex ('Rumalon') in patients with osteoarthritis of the hip or knee."
03/01/1970 - "A double-blind controlled trial of Rumalon in the treatment of painful osteoarthrosis of the hip."
09/01/2000 - "A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon) as a structure modifying therapy in osteoarthritis of the hip and knee."
02/01/2000 - "To assess the immunogenic properties of the glycosaminoglycan peptide complex Rumalon, an aqueous extract of bovine cartilage and bone marrow frequently used in patients with osteoarthritis (OA). "
|2.||Joint Diseases (Joint Disease)
|3.||Hip Osteoarthritis (Coxarthrosis)
01/01/1997 - "Rumalon is an effective agent against pain syndrome in gonarthrosis patients, preserves and improves joint function. "
02/01/2000 - "Whether these phenomena can be correlated with the postulated therapeutic effect of Rumalon in patients with OA remains to be seen, but pain relief via release of endorphins by Th2 cells could be one explanation."
01/01/1984 - "[Erroneous prescription of rumalon to rheumatoid arthritis patients]."
01/01/1984 - "The author describes 2 cases of erroneous prescription of rumalon to patients with rheumatoid arthritis (RA), as a result of which in one of the patients oligoarthritis arthritis while in the other one the typical seropositive slow-progressing rheumatoid arthritis transformed to RA with systemic manifestations."
11/01/1995 - "Drugs which potentially protect cartilage from damage, such as orgotein, glycosaminoglycan polysulphate (Arteparon), and Rumalon, may prove useful in rheumatoid arthritis; they have been studied in osteoarthritis, but there is evidence that they protect cartilage from breakdown by inflammation in some animal models. "
|3.||Antirheumatic Agents (DMARD)
|5.||Morphine (MS Contin)
|6.||L-Lactate Dehydrogenase (Lactate Dehydrogenase)
|7.||Immunoglobulin G (IgG)